New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
10:09 EDTZGNX, ACGL, WPPGY, PUBGY, MHP, APA, MSW, X, OMC, GTI, GWAY, SM, NBL, FBROn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: Apache (APA) downgraded to Hold from Buy at Deutsche Bank... Fibria Celulose (FBR) downgraded to Sell from Neutral at Citigroup... GrafTech (GTI) downgraded to Hold from Buy at Jefferies... McGraw-Hill (MHP) downgraded to Neutral from Buy at Lazard Capital... Noble Energy (NBL) downgraded to Neutral from Buy at Sterne Agee... Omnicom (OMC) downgraded to Hold from Buy at Deutsche Bank... Publicis (PUBGY) downgraded to Sell from Hold at Deutsche Bank... SM Energy (SM) downgraded to Hold from Buy at Deutsche Bank... U.S. Steel (X) downgraded to Underperform from Neutral at Longbow... WPP PLC (WPPGY) downgraded to Hold from Buy at Deutsche Bank... Greenway Medical (GWAY) downgraded to Underperform from Neutral at Sterne Agee... Corcept Therapeutics (MHP) downgraded to Neutral from Outperform at Cowen... Arch Capital (ACGL) downgraded to Hold from Buy at Stifel Nicolaus.. Mission West Properties (MSW) downgraded to Hold from Buy at Stifel Nicolaus... Zogenix (ZGNX) downgraded to Hold from Buy at Stifel Nicolaus.
News For APA;FBR;GTI;MHP;NBL;OMC;PUBGY;SM;X;WPPGY;GWAY;MSW;ACGL;ZGNX From The Last 14 Days
Check below for free stories on APA;FBR;GTI;MHP;NBL;OMC;PUBGY;SM;X;WPPGY;GWAY;MSW;ACGL;ZGNX the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 15, 2014
18:58 EDTZGNXOn The Fly: After Hours Movers
Subscribe for More Information
16:07 EDTZGNXZogenix confirms reversal of Zohydro sales ban in Massachusetts
Subscribe for More Information
15:33 EDTZGNXZogenix wins reversal of Zohydro sales ban in Mass., Boston Globe says
A federal judge ruled that Massachusetts cannot block sales of Zogenix's Zohydro in the state, as had been previously ordered by Governor Deval Patrick, reports The Boston Globe. Reference Link
14:33 EDTZGNXJudge strikes down ban on Zogenix's Zohydro, Boston Globe says
Subscribe for More Information
09:02 EDTGTIGrafTech urges shareholders to vote for director nominees at annual meeting
Subscribe for More Information
08:17 EDTNBLNoble Energy announces CEO Charles Davidson plans to retire
Subscribe for More Information
06:47 EDTGTIGrafTech likely to become embroiled in proxy battle, NY Times says
Subscribe for More Information
April 14, 2014
07:46 EDTGTIGrafTech says stands behind prior investigation, process and findings
Subscribe for More Information
April 13, 2014
15:32 EDTGTI'Save GrafTech' responds to settlement proposal rejection by Graftech
Nathan Milikowsky, a former GrafTech International director and a holder of over 15M GrafTech shares, or over 11.2%, of the common stock, sent a letter to GrafTech in response to the company’s rejection of Save GrafTech’s latest settlement proposal. Save GrafTech has nominated five directors for election to the board of directors of GrafTech at the company’s annual meeting of stockholders on May 15. The letter said in part: "On April 11, Save GrafTech proposed a settlement offer for minority representation on a newly reconstituted 10-member Board...Save GrafTech also proposed a solution to address any concerns the company might have about my suitability to rejoin the board...Having served on the Board with your current directors, I was not surprised that GrafTech rejected this eminently reasonable offer and responded in less than eight hours with an unacceptable counter-proposal. However, I was surprised that this rejection clearly betrays the board’s lack of confidence in the “findings" of its own Special Committee investigation, which was the pretext for excluding me from continuing to serve as a director in 2013...It is unfortunate that our settlement discussions have been scuttled by GrafTech’s inability to accept an exceptionally reasonable offer, which included minority representation for the Save GrafTech slate as well as a significant two-year standstill provision...I look forward to providing shareholders with a platform for truly meaningful change at the 2014 Annual Meeting. "
April 9, 2014
10:06 EDTAPAOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
10:02 EDTXBofA/Merrill's US autos/auto parts analyst has analyst/industry conference call
Subscribe for More Information
09:11 EDTZGNXOn The Fly: Pre-market Movers
Subscribe for More Information
09:00 EDTZGNXZogenix rises 8.9%
Zogenix is up 8.9%, or 23c, to $2.82
07:48 EDTXBofA/Merrill's steel analysts hold an analyst/industry conference call
Subscribe for More Information
06:55 EDTAPAApache downgraded to Hold from Buy at Deutsche Bank
Subscribe for More Information
06:01 EDTAPAApache downgraded to Hold from Buy at Deutsche Bank
05:16 EDTZGNXZogenix requested order staying the ban of Zohydro in MA
Today Zogenix presented its case in U.S. District Court in Boston requesting an immediate order staying the ban on the FDA-approved prescription drug product, Zohydro ER extended-release capsules, entered on March 27, by Massachusetts Governor Deval Patrick. A follow-up hearing has been scheduled for Monday, April 14. The company will continue to monitor, evaluate and take appropriate actions in all states specific to Zohydro ER to ensure that all FDA-approved Schedule II prescription opioids covered by the FDA mandated Risk Evaluation Mitigation Strategy for extended-release and long-acting opioid analgesics receive equal treatment for any rules that impact patient access and prescribing.
April 8, 2014
14:11 EDTNBLWoodside expected to reach deal with Israel on Leviathan tax, Globes says
Subscribe for More Information
April 7, 2014
16:15 EDTZGNXZogenix files suit against Massachusetts to block ban of Zohydro ER
Subscribe for More Information
07:37 EDTOMCApple considered dumping long-time ad agency, WSJ reports
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use